Hello. This is GCCL, your trusted clinical sample analysis partner.
We’re excited to announce our participation in the upcoming INTERBIZ Bio Partnering & Investment Forum 2025,
held from July 2 to July 4 at Phoenix Island, Jeju.
As a partnering company, GCCL will be joining networking sessions with leading Korean biopharma companies and CROs,
exploring opportunities for collaboration in clinical development.
📍 INTERBIZ Bio Partnering & Investment Forum 2025
🗓️ July 2 (Wed) – July 4 (Fri), 2025
📌 Phoenix Island, Jeju, Korea – Participating in business partnering sessions
Since 2002, INTERBIZ has grown into Korea’s largest open innovation platform in the bio-health sector.
It brings together stakeholders across industry, academia, research institutes, startups, and venture companies
to explore collaboration in drug development, technology transfer, R&D partnerships, and investment.
Now in its 23rd year, the forum continues to serve as a key venue for building partnerships
and creating synergy across the life science ecosystem.
GCCL is a GCLP-certified central lab and clinical sample analysis CRO that supports the full drug development lifecycle.
With our integrated Bioanalytical Lab, Central Lab, and R&D Lab platforms,
we’ve been a reliable partner to domestic and global pharmaceutical companies and CROs.
At INTERBIZ 2025, we look forward to connecting with:
✔ Korean drug developers
✔ Clinical CRO professionals
We welcome the opportunity to share insights on sample analysis-based collaboration models and analytical strategies tailored to each R&D phase.
As your end-to-end analytical partner in clinical development, GCCL is committed to delivering value, trust, and scientific excellence.
Click the banner below to learn more about us!
> About GCCL > Newsroom > Company News